Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sun Pharmaceutical Industries Limited ( (IN:SUNPHARMA) ) just unveiled an announcement.
Sun Pharmaceutical Industries Limited announced that its wholly-owned subsidiary, Sun Pharma Laboratories Limited, has approved a significant investment of INR 3,000 crores to establish a new greenfield formulations manufacturing facility in Madhya Pradesh. This strategic move is expected to enhance the company’s manufacturing capabilities and strengthen its position in the pharmaceutical industry, potentially impacting stakeholders by expanding production capacity and creating new opportunities in the market.
More about Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company is a leading player in the global pharmaceutical market, with a strong emphasis on innovation and quality.
Average Trading Volume: 88,047
Technical Sentiment Signal: Strong Buy
Current Market Cap: 4337.5B INR
Find detailed analytics on SUNPHARMA stock on TipRanks’ Stock Analysis page.